Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

doi:10.3389/fonc.2022.861963

Editorial

. 2022 Mar 4:12:861963.

doi: 10.3389/fonc.2022.861963. eCollection 2022.

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

Kiyohiro Ando¹, Takaomi Sanda², Yusuke Suenaga³, Tao Liu^{4

5}

Affiliations

¹ Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
² Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
³ Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan.
⁴ School of Women's and Children's Health, University of New South Wales Sydney, Sydney, NSW, Australia.
⁵ Children's Cancer Institute, Sydney, NSW, Australia.

PMID: 35311141
PMCID: PMC8931025
DOI: 10.3389/fonc.2022.861963

Editorial

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

Kiyohiro Ando et al. Front Oncol. 2022.

. 2022 Mar 4:12:861963.

doi: 10.3389/fonc.2022.861963. eCollection 2022.

Authors

Kiyohiro Ando¹, Takaomi Sanda², Yusuke Suenaga³, Tao Liu^{4

5}

Affiliations

¹ Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
² Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
³ Department of Molecular Carcinogenesis, Chiba Cancer Center Research Institute, Chiba, Japan.
⁴ School of Women's and Children's Health, University of New South Wales Sydney, Sydney, NSW, Australia.
⁵ Children's Cancer Institute, Sydney, NSW, Australia.

PMID: 35311141
PMCID: PMC8931025
DOI: 10.3389/fonc.2022.861963

No abstract available

Keywords: copy number variation (CNV); epigenetic regulation; intracranial metastasis (IM); neuroblastoma; noncoding RNA (ncRNA).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Editorial on the Research Topic Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

Affiliations

Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Publication types

LinkOut - more resources

Full Text Sources